ArticleClinical ophthalmology (Auckland, N.Z.)2026

Two-Year Real-World Outcomes of Faricimab in Treatment-Resistant Neovascular Age-Related Macular Degeneration.

Eslam Ahmed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.